In this low interest rate environment, dividends are still looking great, and here are over 50 companies going ex-dividend over the next week to review More
-
-
Sponsored By:
-
Sponsored By:
TEVA
Recent Articles
OPKO Health’s Healthy Buyout Binge
This healthcare name is rapidly building up a business worth watching. And the possibility of OPKO itself getting bought out isn't too remote. More
9 Pharmaceutical Stocks to Sell Now
This week, the overall grades of nine Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
12 Intraday Movers and Shakers
Don't miss the 3%-7% moves on these momentum stocks before market close today More
Biotech Movers: A Tough Week All Around
Amarin Corp. slides on dashed buyout hopes, while Sarepta, Galena and others also faced serious setbacks. More
Bayer to Buy Schiff Nutrition for $1.1B
Shares of vitamin maker Schiff Nutrition (SHF) soared Wednesday on news of a buyout by pharmaceutical giant Bayer AG. More
FDA Pulls Approval for a Generic Antidepressant
A generic version of antidepressant Wellbutrin has lost FDA approval after tests showed it less effective than the brand name drug at a certain dosage. More
